PE20142438A1 - Uso intrauterino de 18-metil-15b,16b-metilen-19-nor-20-espirox-4-en-onas, sistemas intrauterinos que contienen 18-metil-15b,16b-metilen-19-nor-20-espiox-4-en-3-onas, asi como su uso en la anticoncepcion y terapia ginecologica - Google Patents

Uso intrauterino de 18-metil-15b,16b-metilen-19-nor-20-espirox-4-en-onas, sistemas intrauterinos que contienen 18-metil-15b,16b-metilen-19-nor-20-espiox-4-en-3-onas, asi como su uso en la anticoncepcion y terapia ginecologica

Info

Publication number
PE20142438A1
PE20142438A1 PE2014001786A PE2014001786A PE20142438A1 PE 20142438 A1 PE20142438 A1 PE 20142438A1 PE 2014001786 A PE2014001786 A PE 2014001786A PE 2014001786 A PE2014001786 A PE 2014001786A PE 20142438 A1 PE20142438 A1 PE 20142438A1
Authority
PE
Peru
Prior art keywords
methyl
onas
methylen
intrauterine
contraception
Prior art date
Application number
PE2014001786A
Other languages
English (en)
Inventor
Norbert Schmees
Lars Rose
Tuula Valo
Katja Prelle
Reinhard Nubbemeyer
Henriikka Korolainen
Harri Jukarainen
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48142002&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20142438(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of PE20142438A1 publication Critical patent/PE20142438A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Referida derivados de 18-metil-15(beta),16(beta)-metilen-19-nor-20-espirox-4-en-3-onas de la formula general (1), donde R6 y R7 son H o juntos son un grupo alfa-metileno. Tambien esta referida a un sistema intrauterino que contiene compuestos de la formula 1. Dichos compuestos son utiles en la anticoncepcion y en la terapia ginecologica
PE2014001786A 2012-04-23 2013-04-19 Uso intrauterino de 18-metil-15b,16b-metilen-19-nor-20-espirox-4-en-onas, sistemas intrauterinos que contienen 18-metil-15b,16b-metilen-19-nor-20-espiox-4-en-3-onas, asi como su uso en la anticoncepcion y terapia ginecologica PE20142438A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102012206652 2012-04-23

Publications (1)

Publication Number Publication Date
PE20142438A1 true PE20142438A1 (es) 2015-02-01

Family

ID=48142002

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2014001786A PE20142438A1 (es) 2012-04-23 2013-04-19 Uso intrauterino de 18-metil-15b,16b-metilen-19-nor-20-espirox-4-en-onas, sistemas intrauterinos que contienen 18-metil-15b,16b-metilen-19-nor-20-espiox-4-en-3-onas, asi como su uso en la anticoncepcion y terapia ginecologica

Country Status (28)

Country Link
US (1) US20150065472A1 (es)
EP (1) EP2841074A1 (es)
JP (1) JP2015514791A (es)
KR (1) KR20150004807A (es)
CN (1) CN104254333A (es)
AR (1) AR090799A1 (es)
AU (1) AU2013254840A1 (es)
BR (1) BR112014026193A2 (es)
CA (1) CA2871003A1 (es)
CL (1) CL2014002836A1 (es)
CO (1) CO7111255A2 (es)
CR (1) CR20140490A (es)
CU (1) CU20140121A7 (es)
DO (1) DOP2014000241A (es)
EA (1) EA201491922A1 (es)
EC (1) ECSP14024250A (es)
HK (1) HK1205000A1 (es)
IL (1) IL235095A0 (es)
IN (1) IN2014DN07839A (es)
MA (1) MA37444A1 (es)
MX (1) MX2014012849A (es)
PE (1) PE20142438A1 (es)
PH (1) PH12014502372A1 (es)
SG (1) SG11201406582XA (es)
TN (1) TN2014000444A1 (es)
TW (1) TW201350122A (es)
UY (1) UY34758A (es)
WO (1) WO2013160213A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015055789A1 (en) * 2013-10-17 2015-04-23 Bayer Pharma Aktiengesellschaft INTRAVAGINAL USE OF 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, INTRAVAGINAL RINGS COMPRISING 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, AND USE THEREOF IN CONTRACEPTION

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI90627C (fi) 1992-07-31 1994-03-10 Leiras Oy Laitteisto lääkeainesauvan varustamiseksi vaipalla
PH30867A (en) 1992-07-31 1997-12-09 Leiras Oy Method and equipment for installing a medicine capsule on a support.
FI107339B (fi) 1998-06-30 2001-07-13 Leiras Oy Lääkeaineiden läpäisynopeutta säätävä kalvo tai matriisi
US6056976A (en) 1998-11-12 2000-05-02 Leiras Oy Elastomer, its preparation and use
PL201878B1 (pl) * 2000-01-18 2009-05-29 Bayer Schering Pharma Ag Kompozycja farmaceutyczna w doustnej postaci dawkowania. zawierająca estrogen i drospirenon, zastosowanie kompozycji i preparat farmaceutyczny
CA2771944A1 (en) * 2003-07-16 2005-01-27 Teva Women's Health, Inc. Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
DE102006030416A1 (de) * 2006-06-29 2008-01-03 Bayer Schering Pharma Ag 18-Methyl-19-nor-androst-4-en-17,17-spiroether (18-Methyl-19-nor-20-spirox-4-en-3-one) sowie diese enthaltende pharmazeutische Präparate
DE102007011105A1 (de) * 2007-03-02 2008-09-04 Bayer Schering Pharma Aktiengesellschaft Mineralcorticoid-Rezeptor-Antagonisten zur Behandlung von Endometriose
DE102007063495A1 (de) * 2007-12-29 2009-09-17 Bayer Schering Pharma Aktiengesellschaft 19-Nor-Steroidderivate mit einer 15α,16α-Methylengruppe und einem gesättigten 17,17-Spirolactonring, deren Verwendung sowie diese Derivate enthaltende Arzneimittel
DE102007063496A1 (de) * 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 15,16-Methylen-17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-on-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
EP2140860A1 (en) * 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
PT2012063262W (pt) * 2010-11-08 2015-06-11 Hll Lifecare Ltd Um novo dispositivo intra-uterino com libertação controlada de cobre

Also Published As

Publication number Publication date
AR090799A1 (es) 2014-12-10
EP2841074A1 (de) 2015-03-04
BR112014026193A2 (pt) 2017-06-27
TN2014000444A1 (en) 2016-03-30
WO2013160213A1 (de) 2013-10-31
UY34758A (es) 2013-11-29
US20150065472A1 (en) 2015-03-05
ECSP14024250A (es) 2015-12-31
HK1205000A1 (en) 2015-12-11
MX2014012849A (es) 2015-02-05
SG11201406582XA (en) 2014-11-27
CL2014002836A1 (es) 2015-03-13
TW201350122A (zh) 2013-12-16
CU20140121A7 (es) 2014-12-26
IL235095A0 (en) 2014-12-31
CN104254333A (zh) 2014-12-31
CO7111255A2 (es) 2014-11-10
MA37444A1 (fr) 2016-11-30
PH12014502372A1 (en) 2015-01-26
KR20150004807A (ko) 2015-01-13
CR20140490A (es) 2014-11-17
DOP2014000241A (es) 2014-12-31
IN2014DN07839A (es) 2015-04-24
EA201491922A1 (ru) 2015-04-30
CA2871003A1 (en) 2013-10-31
JP2015514791A (ja) 2015-05-21
AU2013254840A1 (en) 2014-11-06

Similar Documents

Publication Publication Date Title
CL2016002735A1 (es) Compuestos de imidazo[4,5-c]quinolin-2-ona y su uso para tratar cáncer
CL2017001930A1 (es) Derivados de 4h-pirrol[3,2-c]piridin-4-ona
CR20140365A (es) Compuestos de carbamato y preparación y uso de los mismos
UY35500A (es) Indazoles sustituidos con heteroarilo
CU24273B1 (es) COMPUESTOS ß-LACTÁMICOS SUSTITUIDOS CON AMIDINA Y SU MÉTODO DE PREPARACIÓN
UY34632A (es) Compuestos de oxazolidin- 2- ona y usos de los mismos
UY34566A (es) 1,4?dihidropirimidinas 4,4?disustituidas y su uso como medicamentos para el tratamiento de la hepatitis b
CO6592042A2 (es) Derivados de n3-sustituido -n1-sulfonil-5-fluorpirimidinona
CL2017002856A1 (es) Compuestos de tioéter como inhibidores de la nitrificación
EA201591196A1 (ru) Композиции и способы для трансдермальной доставки гормонов и других лекарственных средств
BR112015030308A2 (pt) antagonistas de progesterona de imidazolila
CO7350653A2 (es) Retinoides y uso de los mismos
CR20160176A (es) Sistema de administración intrauterina
PE20142438A1 (es) Uso intrauterino de 18-metil-15b,16b-metilen-19-nor-20-espirox-4-en-onas, sistemas intrauterinos que contienen 18-metil-15b,16b-metilen-19-nor-20-espiox-4-en-3-onas, asi como su uso en la anticoncepcion y terapia ginecologica
AR094057A1 (es) Compuestos amina y uso de los mismos como neutralizantes de voc bajo o cero
GT201400225A (es) Uso de 18-metil-15b,16b-metilen-19-nor-20-espirox-4-en-3-onas en el tratamiento de menorragia, y sistemas intrauterinos que comprenden 18-metil-15b.16b-metilen-19-nor-20-espirox-4-en-3-onas para el tratamiento de trastornos con sangrado uterino
AR098060A1 (es) Sistema de administración intrauterina
UA89388U (ru) Применение глюкозамина гидрохлорида как средства, защищающего организм от системного воздействия высоких температур
ITNA20130021U1 (it) "dispositivo medico - chirurgico che ha applicazione nel campo della odontoiatria, quale sistema di fissaggio di protesi dentaria mobile alla arcata dentaria".
ECSP12012115A (es) 5-alquinil-pirimidinas
UA112315C2 (uk) Внутрішньоматкові системи, пристрої введення пристроїв iud (внутрішньоматкових пристроїв) і пов'язані з ними способи і набори
UY33816A (es) ?nuevas triazolilfenil sulfonamidas como inhibidores de serina/treonina cinasa?.

Legal Events

Date Code Title Description
FD Application declared void or lapsed